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Background. Empirical data showing the clear benefits of exclusive breastfeeding (EBF) for HIV prevention are needed to
encourage implementation of lactation support programs for HIV-infected women in low resource settings among whom
replacement feeding is unsafe. We conducted a prospective, observational study in Lusaka, Zambia, to test the hypothesis that
EBF is associated with a lower risk of postnatal HIV transmission than non-EBF. Methods and Results. As part of a randomized
trial of early weaning, 958 HIV-infected women and their infants were recruited and all were encouraged to breastfeed
exclusively to 4 months. Single-dose nevirapine was provided to prevent transmission. Regular samples were collected from
infants to 24 months of age and tested by PCR. Detailed measurements of actual feeding behaviors were collected to examine,
in an observational analysis, associations between feeding practices and postnatal HIV transmission. Uptake of EBF was high
with 84% of women reporting only EBF cumulatively to 4 months. Post-natal HIV transmission before 4 months was
significantly lower (p=0.004) among EBF (0.040 95% CI: 0.024–0.055) than non-EBF infants (0.102 95% CI: 0.047–0.157); time-
dependent Relative Hazard (RH) of transmission due to non-EBF=3.48 (95% CI: 1.71–7.08). There were no significant
differences in the severity of disease between EBF and non-EBF mothers and the association remained significant (RH=2.68
95% CI: 1.28–5.62) after adjusting for maternal CD4 count, plasma viral load, syphilis screening results and low birth weight.
Conclusions. Non-EBF more than doubles the risk of early postnatal HIV transmission. Programs to support EBF should be
expanded universally in low resource settings. EBF is an affordable, feasible, acceptable, safe and sustainable practice that also
reduces HIV transmission providing HIV-infected women with a means to protect their children’s lives. Trial Registration.
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INTRODUCTION
Promotion of exclusive breastfeeding (EBF) has been a cornerstone
of public health measures to promote child survival for several
decades [1,2]. EBF is associated with lower risks of diarrhea- and
pneumonia-related infant morbidity and mortality than breast-
feeding with addition of other fluids and solids in both developed
and developing world settings [3–6]. EBF facilitates normal
physiological regulation of milk production, which depends on
regular infant suckling, allowing for a healthy balance between the
infant’s needs and the amount of milk produced [7]. This
regulation helps prevent milk stasis that underlies the development
of mastitis and other breast problems [8] thereby being the
healthiest practice for both mothers and infants.
Despite the well-established benefits of EBF in the absence of
HIV, initial findings from Durban, South Africa, that the risk of
post-natal HIV transmission was lower with EBF than with non-
EBF [9,10] were met with some skepticism [11–13]. As with all
epidemiologic associations based on health-related behaviors that
cannot be randomly assigned, it was difficult to rule out reverse
causality, i.e. mothers of infected children choosing non-EBF,
rather than EBF reducing risks of HIV infection, and confounding,
i.e. a third factor related to transmission and to the likelihood of
non-EBF, as possible explanations for the findings. Nevertheless,
the finding was soon confirmed by a second large study conducted
in Zimbabwe [14] and by a new study in KwaZulu-Natal, South
Africa [15].
The public health benefits of EBF in low resource settings could
be substantial. EBF can be practiced by women regardless of their
HIV status thus avoiding the stigma of distinguishing infant
feeding practices by maternal serostatus. Any reduction of HIV
transmission due to EBF, would simply add to its established
benefits for other aspects of infant and maternal health. EBF is
unlike replacement feeding where reduction of HIV transmission
has to be carefully balanced against increased mortality due to
other infections. Support for EBF programs would be strengthened
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prevention. Here we present the results of a prospective,
observational study in Lusaka, Zambia, designed to test the a
priori hypothesis that EBF is associated with a lower risk of early
postnatal HIV transmission than non-EBF.
METHODS
Study design
We conducted a prospective, epidemiologic study nested within a
randomized trial evaluating the safety and efficacy of early
weaning [16]. The protocol is available as a supporting document
Protocol S1. We ruled out an experimental design to address the
EBF hypothesis as impractical and unethical since, although the
role of EBF in prevention of HIV transmission was in question at
the time the study was designed, the benefits of this practice for
other aspects of maternal and child health were already well-
established. All women were encouraged to breastfeed exclusively
to 4 months and the study was designed with the a priori objective
of analyzing associations between actual practices and early
postnatal HIV transmission. We improved on previous studies by
including: more frequent measurements of the infants’ HIV status
to more accurately determine the timing of transmission; detailed
questionnaires about feeding practices including 24 hour recall
and feeding history corroborated with counselors’ assessments; and
collection of data necessary to make statistical adjustments for
possible confounding by major risk factors for HIV transmission,
namely maternal CD4 count and viral load.
Study population
HIV-infected women were recruited between May 2001 and
September 2004 from prevention of mother-to-child transmission
(PMTCT) programs established at two antenatal clinics in Lusaka,
Zambia. The programs offered voluntary HIV counseling and
testing with nevirapine prophylaxis [17]. HIV treatment programs
were established in 2004 [18] whereafter consenting, eligible
women at any stage of follow-up were started on first-line
treatment regimens. HIV-seropositive women were eligible for
enrollment if they intended to breastfeed, accepted nevirapine,
had no severe pregnancy complications and agreed to require-
ments of the study. Cotrimoxazole was given to all women with
CD4 counts ,200 after November 2003 [19] and to all infants
from 6 weeks to 12 months of age. At the time the study was
started, PMTCT programs using single-dose nevirapine prophy-
laxis were only beginning to be established [17] and infant formula
was not provided as part of these programs. Given the
disadvantaged economic circumstances of the communities
surrounding the two clinics and the high rates of infectious disease
morbidity and mortality among children in these communities,
replacement feeding was not deemed a safe alternative. All women
signed informed consent. The study was approved by the Human
Subjects Committees at all the investigators’ institutions (Columbia
University, University of Zambia, Boston University, Children’s
Hospital of Los Angeles).
Study Intervention
All women, regardless of their random assignment, were
encouraged to breastfeed exclusively to 4 months. Counseling to
support EBF began at antenatal visits and included education
about HIV transmission reduction. Study counselors were trained
using a modification of the WHO breastfeeding training program
[20]. Orientation sessions were provided to non-study clinical staff
about benefits of EBF. Both clinics had ‘‘baby-friendly’’ policies
[21] in place in their maternity units prior to the study.
Educational messages about EBF were included in community
education and outreach activities, including community drama
presentations and talks. Nurse midwives attending deliveries, even
if not study staff, were trained to support initiation of breastfeeding
as soon as possible after delivery. A home visit scheduled 4 days
after delivery focused on preventing early problems with
breastfeeding initiation. Clinic-based counseling sessions every
month post-partum were conducted by study counselors. Clinic
visits were interspersed between home visits so that contact with
the participant occurred every 2 weeks, up to 6 months of age. In
addition, study participants organized themselves into ‘‘mothers’
support groups’’ who engaged in various income-generating and
self-help activities. The benefits of EBF was a unifying theme that
served to motivate these groups. Infant formula was not provided
before 4 months barring exceptional circumstances e.g. maternal
death, desertion or severe illness.
Participants randomized to the intervention group were encour-
aged to breastfeed exclusively to 4 months and then to stop
breastfeeding abruptly, or as rapidly as possible. Infant formula
and weaning cereal were provided to women in this group at
4 months if they elected to adhere with their random assignment.
Participants randomized to the control group were encouraged to
exclusively breastfeed to 6 months and then to gradually introduce
complementaryfoods(notprovidedbythestudy)while continuingto
breastfeed. The duration of breastfeeding in this group was based on
the women’s informed choice. Women were told their random
assignment usually around 2 months post-partum.
Study procedures
Blood samples were drawn from women at enrollment during
pregnancy. The results of the routine syphilis screening test (RPR)
were recorded and all women with positive results were treated
with penicillin. Questionnaires collected socio-economic and
clinical history data at enrollment. Obstetric and neonatal data
were collected at delivery. Infant heelstick blood samples were
collected onto filter paper on the day of birth, at 1 week, and at 1,
2, 3, 4, 4 K, 5, 6, 9, 12, 15, 18, 21, and 24 months of age. Clinic
visits scheduled at these same time-points included a structured
questionnaire about infant feeding practices. Questions included
24 hour, one week and since the last visit recall about infant
consumption of any non-breast milk substances (classified as non-
human milks, non-milk liquids, solids and semi-solids, fermented
products, medicines, and other). Those administering the
questionnaire were separate individuals to those performing the
counseling and were trained to ask each question, not conditional
on global screening questions. Questions were asked about the
frequency of feeding all non-breast milk items and reasons for any
non-EBF. The questionnaire modified an earlier version devel-
oped by WHO [22]. As a separate assessment, counselors
recorded their opinion following the counseling session as to
whether breastfeeding was exclusive or not.
Laboratory methods
Maternalblood collected atenrollment wastested for CD4 and CD8
counts (FACSCount system, BD Immunocytometry Systems, San
Jose, CA), hemoglobin (HemocueH system, Lake Forest, CA) and
plasma viral load (Roche AmplicorH 1.5, Branchburg, NJ). Infant
heelstick samples were tested in batches for HIV-1 DNA by realtime
PCR. All positives were confirmed on at least 2 samples if available.
If the child died or no further samples were available, then the same
sample was re-tested to confirm. All samples were confirmed to have
adequate material by amplification of the beta-globin gene to
minimize false negative results due to inadequate samples.
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For the primary analysis, all randomized mother-infant pairs in
either the intervention and control group were combined. In the
case of multiple surviving infants per woman, the first-born twin
was selected. HIV transmission was treated as a time-to-event
variable using Kaplan-Meier methods to estimate the cumulative
probability of testing HIV positive by 4 months of age (133 days).
Non-EBF was treated as a time-dependent covariate which
changed from EBF to non-EBF irreversibly the first time anything
other than breast milk was reported on the structured question-
naire. Prescribed medicines were allowed but all other non-breast
milk substances (including water) given within the past 24 hours or
at least once per week in the past week or since the last visit
prompted a transition into the non-EBF category. The age non-
EBF started was imputed as 3 days, 10 days and 14 days prior to
the actual dates of the 1 week, 1 month and 2, 3, 4 month visits
respectively. Cox Proportional Hazards models were used to
investigate confounding as follows: characteristics were screened as
potentially associated with postnatal transmission to 4 months,
those associated with transmission (p,0.10) were included one-by-
one with non-EBF and if either significantly associated with
transmission (p,0.05) or if they changed the estimate of the
relative hazard (RH) associated with non-EBF by .10% were
retained. The final Cox model included all variables that met these
criteria when simultaneously entered. Differences in other
characteristics were tested using chi-squared tests if these
characteristics were categorical, t-tests if normally-distributed
continuous and Wilcoxon rank sum tests if non-normal continuous
variables. To investigate age-specific hazard rates of postnatal
transmission, actuarial life-table methods were used. Event time
was censored at the age (in days) when all breastfeeding ended plus
42 days or at the time of first positive test. Event time was divided
by 30.417 to make months the unit of analysis. The failure
probability and the hazard rate were estimated for intervals of
4 months through 24 months. Analysis used SAS software version
9.3.1 (Cary, NC).
RESULTS
Study population
The study randomized 958 live-born infants of HIV-infected
mothers. For this analysis, 56 (5.8%) were excluded because they
had a positive result #3 days (presumed intrauterine infections); 61
(6.4%) were excluded because they had a positive result by 6 weeks
(presumed intrapartum infections); 11 (1.1%) died by 6 weeks of age
without a positive HIV result (6 died with positive results); and 55
(5.7%) were lost to follow-up or had withdrawn by 6 weeks. We also
excluded 41 (5.3%) children known to have stopped breastfeeding
before 4 months. The analysis includes 734 infants surviving HIV-
free to 6 weeks still breastfeeding at 4 months.
Uptake of EBF
Uptake of EBF was excellent. Viewed cross-sectionally, .94% of
women reported EBF at each clinic visit. Viewed longitudinally,
613 (83.5%) of women still breastfeeding at 4 months reported
giving the infant only breast milk up to that point. Non-human
milk was the most commonly given item, followed by other non-
milk liquids. Semi-solids were rarely given. Among those who
reported non-EBF, just under half reported non-EBF in the prior
24 hours. The counselors’ opinion (following the counseling
session) was a poor predictor of whether non-EBF would be
reported in the structured questionnaire (Table 1).
Women who reported non-EBF before 4 months were signif-
icantly more likely to be primiparous, report going out of the home
without the child, be single, have a full-time job, have a water
source inside their home or on their property, have a fridge, and to
have delivered at the tertiary hospital. There were no significant
Table 1. Infant feeding practices reported at each clinic visit through 4 months among 734 HIV-infected mothers and their infants
surviving HIV-free to 6 weeks of age and still breastfeeding to 4 months in Lusaka, Zambia.
..................................................................................................................................................
1 week 1 month 2 months 3 months 4 months
N=693 N=685 N=678 N=672 N=646
N (%) Any report of non-exclusive breastfeeding* 43 (6.2) 29 (4.2) 14 (2.1) 22 (3.3) 32 (5.0)
N (%) given:{
Non-human milk 10 (1.4) 4 (0.6) 3 (0.4) 7 (1.0) 6 (0.9)
Semi-solids 1 (0.1) 1 (0.2) 3 (0.4) 6 (0.9) 11 (1.7)
Non-milk liquids 6 (0.9) 4 (0.6) 3 (0.4) 5 (0.7) 4 (0.6)
Water 9 (1.3) 5 (0.7) 4 (0.6) 5 (0.7) 10 (1.6)
Other{ 20 (2.9) 16 (2.3) 5 (0.7) 6 (0.9) 10 (1.6)
N (%) frequency:
In past 24 hours 18 (41.9) 10 (34.5) 7 (50.0) 9 (42.9) 16 (50.0)
5–7 times per week 2 (4.7) 5 (17.2) 2 (14.3) 2 (9.5) 4 (12.5)
2–4 times per week 6 (13.9) 9 (31.0) 0 2 (9.5) 6 (18.8)
Once per week 17 (39.5) 5 (17.2) 5 (35.7) 8 (38.1) 6 (18.8)
Sensitivity/Specificity of counselors’ opinion1 0.73/0.98 0.50/0.98 0.53/0.98 0.67/0.98 0.44/0.98
*Defined as any non-breast milk liquid or solid (including water) except prescribed medicines reported as having been given in the previous 24 hours or at least once
per week in the past week or since the last clinic visit.
{Given in the past 24 hours or at least once per week. More than one item could be given.
{Other included cooking oil, castor oil, and herbal medicines
1Sensitivity and specificity of the counselors’ opinion was calculated assuming that the self-reports of non-exclusive breastfeeding on the standardized questionnaire
were the ‘‘gold standard.’’
doi:10.1371/journal.pone.0001363.t001
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non-EBF women (Table 2).
Reduced HIV transmission with EBF
The risk of post-natal HIV transmission before 4 months was
significantly lower among 613 women who reported EBF
(cumulative probability of a positive PCR by 4 months 0.040
[n=24] 95% CI: 0.024–0.055) compared to among 121 who
reported non-EBF (0.102 [n=12] 95% CI: 0.047–0.157)
(p=0.004) (Figure 1). In unadjusted analysis, non-EBF (defined
as time-dependent covariate) was associated with .3-fold
increased risk of early postnatal HIV transmission (RH=3.48
95% CI: 1.71–7.08) (Table 3). The risk was slightly increased
(RH=4.04 95% CI: 1.87–8.71) if the analysis was restricted to
those 727 pairs with negative PCR results .28 days (a more
stringent analysis ensuring that infections detected .6 weeks were
not due to intrapartum infections detected late).
The questionnaire asked about why breastfeeding was not
exclusive. The most common reason was that the infant was either
crying or sick (n=41). If these pairs were excluded, there
continued to be a significant association between non-EBF and
transmission (RH=2.92 95% CI: 1.19–7.14). The other reasons
given for non-EBF were that the child was cared for by others
(n=24), the mother was advised to do so (n=14), insufficient milk
(n=6), to relieve child constipation (n=3), other (n=5) and no
reason given or denies non-EBF (n=28).
We examined the consequences of defining non-EBF in
different ways. If non-EBF was defined as giving the child non-
human milk, semi-solids or non-milk liquids only (i.e. allowing
water or ‘‘other’’ items to be given) in the last 24 hours or at least
once per week, then the association with transmission was slightly
stronger (RH=5.56 95% CI: 2.43–12.74). Giving water or
‘‘other’’ substances was not associated with a significant increase
in transmission (RH=1.87 95% CI: 0.73–4.81).
We also examined associations by the regularity of non-EBF.
Surprisingly, we found stronger associations with increased
transmission with less regular relative to more regular non-EBF.
If non-EBF was defined as giving the child any non-breast milk
items 5 or more times per week or within the past 24 hours, the
association with transmission was weaker (RH=2.04 95% CI:
0.72–5.78) than if non-EBF was defined as giving any non-breast
milk items less regularly i.e. 1–4 times per week and not in the last
24 hours (RH=4.12 95% CI: 1.93–8.79).
To investigate if differences between the women who practiced
non-EBF explained the association, we conducted multivariate
analyses adjusting for other risk factors for early postnatal
transmission. The association between non-EBF and higher risk of
post-natal HIV transmission was slightly attenuated but remained
significant (RH=2.68 95% CI: 1.28–5.62) after adjusting for
maternal CD4 count, plasma viral load, syphilis screening results
and low birthweight (Table 3). None of the socioeconomic or other
characteristics that differed between women reporting EBF or non-
EBF were associated with postnatal transmission, nor did their
inclusion influence the EBF-transmission association.
Maternal CD4 count was a strong predictor of early post-natal
transmission with 86.1% of early postnatal infections occurring
among women with CD4 counts ,350. Among women with CD4
counts ,350, the cumulative probability of postnatal HIV
transmission by 4 months was 0.191 (95% CI: 0.095–0.288) for
non-EBF (n=65) and 0.063 (95% CI: 0.036–0.091) for EBF
(n=306); RH=3.40 (95% CI: 1.58–7.33) after adjusting for viral
load, syphilis status and low birthweight. Among women with
CD4 counts .350, there were no infections by 4 months for non-
EBF (n=56) and the cumulative probability of postnatal
transmission was 0.017 (95% CI: 0.002–0.031) for EBF (n=307).
Six women started on antiretroviral therapy during pregnancy.
If these women are excluded and person-time censored when an
additional 3 women started on therapy after delivery, the
association between non-EBF and transmission remained un-
changed (RH=3.09 95% CI 1.25–7.64 adjusted for viral load,
CD4 count, syphilis status and birthweight).
Reverse causality
To investigate reverse causality i.e. child HIV infection increasing
the likelihood of non-EBF, rather than non-EBF increasing the
likelihood of HIV infection, we examined the association between
EBF and intrauterine and intrapartum-acquired infections. These
two routes of infection cannot be influenced by postnatal
circumstances. Defining non-EBF as giving any non-breast milk
item to the infant before 4 months, there was no association with
intrauterine infection (RH=0.83 95% CI 0.42–1.65) or intrapar-
tum infection (RH=1.18 95% CI: 0.65–2.14). If the definition of
non-EBF was revised to be non-EBF before 1 month of age, there
remained no association with intrauterine transmission (RH=1.09
95% CI: 0.50–2.42), but there was a slight, non-significant,
increase in intrapartum transmission (RH=1.75 95% CI: 0.89–
3.44) suggesting a small proportion of postnatal transmission may
have been misclassified as intrapartum.
Postnatal transmission older than 4 months
As an alternative approach to considering the role of non-EBF in
HIV transmission, we investigated age-specific hazard rates of
postnatal transmission over 4 month intervals using actuarial life-
table methods. Since the design of the study specifically attempted
to stop all breastfeeding at 4 months in the intervention group, we
only included post-4 month data from the control group. The
median duration of breastfeeding in the control group was
16 months (interquartile range 11–19 months). All women in the
control group were encouraged to introduce complementary foods
by 6 months. Therefore early transmission is predominantly EBF
(.80% reported only EBF) whereas the later transmission is all
non-EBF (all had introduced complementary foods by 6 months).
Although the proportion exclusively breastfeeding declined to zero
at older child ages, the hazard of postnatal transmission
(instantaneous probability of HIV infection per month of
breastfeeding) did not increase with child age. Rather, in the first
4 months, the overall hazard rate was 0.0107 (,1.1% per month)
(95% CI: 0.0052–0.0161). In the intervals 5–8 months and 9–
12 months, the hazard rate remained in the 1% per month range.
After 12 months, it declined to ,0.5% per month over the 12–
24 month period (hazard=0.0052 95% CI: 0.0014–0.0091).
For comparison using this method, the monthly hazard in the first
4m o n t h sw a s,1%amongtheEBFgroup(0.008595%CI:0.0048–
0.0122) compared to 2.4% per month among the non-EBF over this
period (0.0244 95% CI: 0.0100–0.0389). Thus, there was a
significant decline in the hazard of postnatal non-EBF HIV
transmission from ,2.4% per month during the first 4 months,
declining to ,1% per month over the interval 5–12 months, and
,0.5% per month after 12 months (Figure 2, Table 4).
DISCUSSION
Our data demonstrate that infants of HIV-infected mothers who
are breastfed exclusively to 4 months are at least 50% less likely to
acquire HIV infection through breastfeeding. The reduction in
HIV transmission associated with EBF remained significant after
adjustment for both maternal CD4 count and viral load. This
HIV & Exclusive Breastfeeding
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due to sicker women self-selecting non-EBF. Our findings also
strongly argue that reverse causality (i.e. illness among infected
children prompting non-EBF behaviors, rather than non-EBF
being a cause of infection) does not explain the association since
we observed no association between non-EBF and intrauterine/
intrapartum transmission.
Discussions of possible mechanisms underlying the benefits of
EBF for HIV transmission have focused on inflammation or
activation within the infant gut as a result of the introduction of
foreign antigens, contaminants and pathogens [9,10,14,15,23]. We
speculate that there may be additional processes including
elevations in breast milk vial load as a result of decreased
frequency of infant suckling. Since the frequency of milk removal
dictates the rate of milk secretion [24], small changes, such as a
missed feed or an irritable infant not suckling as much as usual,
may result in some milk stasis (breast engorgement). If not reversed
within a short period of time, epithelial permeability may increase
(leaky tight junctions) [25,26], allowing more efficient paracellular
transfer of both cell-free and cell-associated HIV [25]. In a prior
report, we demonstrated that breast milk HIV RNA concentra-
tions increased dramatically following abrupt weaning [27]. We
also reported here, intriguingly, that irregular, rather than regular,
use of non-breast milk items was associated with stronger
associations with transmission. We speculate that the shifts in
breast feeding frequency that occur with non-EBF, particularly if it
is irregular, may disrupt the efficiency of milk removal and may
increase the infectivity of breast milk.
Our counseling program encouraged EBF in conjunction with
other standard messages related to lactation support, including
education about initiation of breastfeeding immediately after
Table 2. Characteristics of the 734 HIV-infected women and
their infants by whether or not they practiced exclusive
breastfeeding (EBF) to 4 months
......................................................................
Characteristic*
EBF
n=631
Non-EBF
n=121 p-value
N (%) N (%)
Mean age (years) 26.5 25.8 0.15
Parity:
First child 68 (11.1) 25 (20.7)
2
nd–3
rd 417 (68.0) 72 (59.5)
$Fourth 128 (20.9) 24 (19.8) 0.02
Median duration (months) of
breastfeeding for last child{
18 19 0.17
EBF $4 months for last child{ 393 (72.2) 61 (63.5) 0.09
One or more children have died{ 216 (40.4) 47 (47.0) 0.12
Disclosed HIV status to partner 351 (57.3) 68 (56.2) 0.83
Reports 0–4 months never gone out
of home without child
341 (55.6) 49 (40.5) 0.002
Married 529 (86.3) 97 (80.2)
Single 50 (8.2) 19 (15.7)
Widowed/divorced/separated 34 (5.5) 5 (4.1) 0.03
No school 33 (5.4) 4 (3.3)
Primary school (,8 years) 309 (50.4) 63 (52.1)
Some high school ($8 years) 222 (36.2) 42 (34.7)
High school completed or more 49 (8.0) 12 (9.9) 0.70
Tap in dwelling or on own property 97 (15.8) 30 (24.8)
Community tap or other 516 (84.2) 91 (75.2) 0.02
Electricity in the home 238 (38.8) 54 (44.6) 0.23
Cooking:
Stove/hotplate 207 (33.8) 50 (41.3)
Charcoal/wood 405 (66.2) 71 (58.7) 0.11
Fridge in the home 71 (11.6) 23 (19.2) 0.02
Report $1 day in past month no food
at home
143 (23.3) 27 (22.3) 0.81
Full-time paid job 36 (5.9) 14 (11.6) 0.02
Place of birth:
Clinic 473 (77.2) 86 (71.1)
Home 64 (10.4) 7 (5.8)
Hospital 72 (11.8) 25 (20.7)
Other 4 (0.6) 3 (2.5) 0.006
Infant sex:
Male 330 (53.9) 57 (47.1)
Female 282 (46.1) 64 (52.9) 0.17
Breastfeeding initiated within:
#30 min 391 (64.4) 76 (64.4)
30–60 min 166 (27.4) 28 (23.7)
.60 min of delivery 50 (8.2) 14 (11.9) 0.38
Mode of delivery:
Cesarean 10 (1.6) 6 (5.0) 0.02
Mean birth weight (grams) 3010 3068 0.29
Infant Birth weight
,2,500 grams 58 (9.5) 12 (9.9) 0.88
Median maternal CD4 count 354 327 0.57
,200 144 (23.5) 30 (24.8)
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Characteristic*
EBF
n=631
Non-EBF
n=121 p-value
N( % ) N( % )
200–349 164 (26.7) 26 (21.5)
350–499 185 (30.2) 36 (29.7)
$500 cells/mm
3 120 (19.6) 29 (24.0) 0.55
Median maternal plasma viral load 29,482 43,989 0.08
,1000 49 (8.0) 9 (7.4)
1,000–9,999 132 (21.6) 20 (16.5)
10,000–99,999 283 (46.3) 55 (45.5)
$100,000 copies/ml 147 (24.1) 37 (30.6) 0.39
Hemoglobin
,10 g/dL 151 (25.0) 36 (30.3) 0.23
RPR positive 108 (18.6) 21 (19.6) 0.81
Body mass index 1 month post-partum
,18.5 86 (14.1) 17 (14.1) 0.99
Experimental group 300 (48.9) 69 (57.0)
Control group 313 (51.1) 52 (43.0) 0.10
*Data shown are the number (percentage) with each characteristic within the
assigned group (unless otherwise indicated e.g. mean/median). Maternal CD4
counts, viral load, hemoglobin, RPR status and eligibility for antiretroviral
therapy were determined based on blood samples and clinical history collected
at enrollment during pregnancy; social and economic characteristics were also
measured at this time.
{Only among those who reported one or more previous liveborn children
doi:10.1371/journal.pone.0001363.t002
Table 2. cont.
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PLoS ONE | www.plosone.org 5 December 2007 | Issue 12 | e1363delivery, correct breastfeeding techniques, frequent on-demand
feeding, and prompt management of breast problems. Counseling
to support lactation reduces the risk of mastitis [28], which is a
strong risk factor for HIV transmission [29,30], and it is likely that
the benefits of EBF for HIV prevention may depend on these
other dimensions of healthy breastfeeding.
Our findings of reduced HIV transmission with EBF are
consistent with at least three other large African studies
[9,10,14,15]. Our estimate of the magnitude of the reduction is
slightly less than reported in these prior studies. This may be
because we used a stringent EBF definition that allowed no
occurrence of any non-breast milk item; the reduction was
stronger if water and ‘‘other’’ items were allowed. The smaller
magnitude may also be because few women gave their infants
semi-solids which has been found to convey the highest risks of
postnatal HIV transmission [15]. Thus the avoidance of infant
formula and semi-solids may be most crucial in the early months of
a breast-fed infant’s life to reduce risks of HIV transmission.
Our study of EBF reported here was an observational sub-study
nested within a clinical trial designed to evaluate whether stopping
all breastfeeding at 4 months improves HIV-free survival of infants
born to HIV-infected mothers. The clinical trial demonstrated no
benefit for HIV-free survival of stopping breastfeeding at 4 months
compared to continuation to a median of 16 months [31]. The
rationale for stopping breastfeeding at 4 months was to avoid any
period of non-EBF since introduction of complementary foods was
recommended at 4–6 months at the time the trial was designed
[32]. Our final results demonstrated that the supposition that all
non-EBF should be avoided was incorrect [31]. Rather, as we
demonstrate here, the risk of post-natal HIV transmission
occurring during non-EBF is greater in the first 4 months of life
and declines as the child becomes older. Non-EBF i.e. continuing
breastfeeding with complementary foods, is developmentally-
appropriate at older ages and conveys less of a risk of HIV
transmission than non-EBF in the first few months of life. The
biological basis for this distinction is not clear but our results are
broadly consistent with several previous studies that have reported
either constant or declining transmission hazards with age [33–
38]. The prior studies are difficult to compare directly since EBF
and non-EBF are not distinguished and feeding practices are likely
to differ substantially across sites as well as over time as different
recommendations about infant feeding by HIV-infected women
have been implemented. The net result is that benefits of reducing
postnatal HIV transmission through early cessation of breastfeed-
ing are too small to offset the high competing risks of mortality
attributable to the absence of breast milk in the diet of an infant
between 4 and 24 months.
Uptake of EBF was excellent in our study with more than 80%
of women reporting only EBF to 4 months. We attribute this high
uptake to the multidimensional intervention which included
intensive and skilled counseling, consistent messages across the
health service, establishment of a mothers’ lactation support
network and active community outreach promoting health
benefits of EBF for all women regardless of their HIV status.
EBF concepts were not new at the study sites since ‘‘baby friendly’’
policies had been part of Zambian guidelines before the study
began. Despite these policies, the demographic health survey in
2001–2002 estimated that 45% of 2–3 month old infants in
Zambia were exclusively breastfed, declining to 15% by 4–
5 months [39]. More research is needed regarding how to achieve
such high uptake of EBF among HIV-infected women in
programmatic settings but our data are encouraging that EBF
can be achieved among a high proportion of HIV-infected women
with a modest intervention in the context of clinical research.
There are several prior studies that have investigated health
services and community-based interventions to improve in EBF
uptake among uninfected women [40–42]. These studies should be
extended to populations with substantial burdens of HIV infection.
Knowledge of the capacity of EBF to reduce HIV transmission
may in fact increase motivation for this practice. Special attention
may be needed for young primiparous mothers and for women
working in the formal sector since these were barriers to EBF in
Figure 1. Cumulative probability of testing HIV positive by PCR through 4 months among 613 exclusively breastfed (EBF) infants and 121 non-
exclusively breastfed (Non-EBF) infants born to HIV-infected women in Lusaka, Zambia. Non-EBF was defined as giving the child any non-breast
milk items (except prescribed medicines) in the past 24 hours or at least once per week at any time before 4 months.
doi:10.1371/journal.pone.0001363.g001
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PLoS ONE | www.plosone.org 6 December 2007 | Issue 12 | e1363Table 3. Risk factors for early postnatal HIV transmission #4 months of age among 734 infants born to HIV-infected women in
Lusaka, Zambia
..................................................................................................................................................
N total N infected
Probability of
infection
Unadjusted relative
hazard (95% CI)
Adjusted relative
hazard (95% CI)"
Exclusive breastfeeding 613 24 0.0398
Non-exclusive breastfeeding 121 12 0.1022 3.48 (1.71–7.08)* 2.68 (1.27–5.62)
Maternal CD4 counts
.350 364 5 0.0141
,350 370 31 0.0855 6.33 (2.46–16.26) 3.19 (1.19–8.55)
Maternal plasma viral load
,10,000 210 2 0.0096
10,000–100,000 338 11 0.0332
.100,000 copies/ml 184 23 0.1284 4.02 (2.28–7.10){ 3.24 (1.71–6.11)
Maternal hemoglobin
.10 g/dL 536 20 0.0380
,10 g/dL 187 16 0.0872 2.32 (1.20–4.48)
RPR status during pregnancy
Negative 558 23 0.0422
Positive 129 11 0.0870 2.14 (1.04–4.39) 2.17 (1.05–4.51){
Infant sex
Male 387 19 0.0498
Female 346 17 0.0505 1.00 (0.52–1.93)
Birthweight
.2500 g 649 29 0.0456
,2500 g 70 6 0.0872 1.98 (0.82–4.77) 1.14 (0.46–2.81)1
Experimental group 369 18 0.0499
Control group 365 18 0.0502 1.01 (0.52–1.93)
*Non-exclusive breastfeeding coded as a time-dependent covariate
{Maternal plasma viral load coded as a continuous variable indicating transmission risk per log10 increase
{A dummy variable for missing RPR status was included in the adjusted model to avoid excluding those missing their RPR status data (n=47)
1Low birthweight was included in the adjusted model because its inclusion reduced the magnitude of the association between non-exclusive breastfeeding and
transmission
"The adjusted model included simultaneously the five covariates displayed in the final column.
doi:10.1371/journal.pone.0001363.t003
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Figure 2. Hazard rates of breastfeeding HIV transmission per month averaged over 4 month intervals through 24 months
doi:10.1371/journal.pone.0001363.g002
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PLoS ONE | www.plosone.org 7 December 2007 | Issue 12 | e1363our study, as is often observed [43]. Further qualitative and social
science research may be helpful to identifying how to implement
effective programs.
In conclusion, we have demonstrated that non-EBF more than
doubles the risk of postnatal HIV transmission in the first 4 months
of life. A 50% reduction in postnatal HIV transmission with a low
cost and sustainable intervention has major public health
implications and a reduction of this magnitude is within the range
of many antiretroviral interventions. Given the important health
benefits of EBF, it is critical that further research be undertaken to
investigate how to achieve good uptake of EBF in the populations
most affected by the HIV pandemic. This is essential so that
effective programs can be implemented as integral components of
PMTCT and antiretroviral treatment programs in low resource
settings. EBF is a safe and effective practice that substantially helps
HIV-infected women protect their children’s lives. We also
encourage strengthening lactation support programs in antenatal,
maternity and well-baby services in the general population to
benefit uninfected mothers and their children as well.
SUPPORTING INFORMATION
Protocol S1 Trial protocol
Found at: doi:10.1371/journal.pone.0001363.s001 (0.12 MB
DOC)
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